中東・アフリカの敗血症診断市場の2028年までの予測- 地域別分析- 製品別、技術別、方法別、検査タイプ別、病原体別、エンドユーザー別

中東・アフリカの敗血症診断市場は、2021年の1,920万米ドルから2028年には3,335万米ドルに成長すると予測されます。2021年から2028年までのCAGRは8.2%を記録すると推定されています。

敗血症診断における技術進歩の高まりが、2021年から2028年にかけて中東・アフリカの敗血症診断市場成長を牽引する

ヘルスケア診断において、正確さを提供し、時間とリソースを節約するために、技術は重要なパラメータとなります。敗血症の診断プロセスにおいて、原因となる病原体の特定は、治療の一環として適切な抗生物質療法を選択する上で不可欠です。分子診断、フローサイトメトリー、マイクロ流体、イムノアッセイ、バイオマーカー、微生物学は、主に敗血症の診断技術として使用されています。中でも分子診断法（MDx）は、敗血症診断のために検討すべき魅力的なアプローチです。分子診断技術の採用は、高感度、高精度、他の技術より短い所要時間など、いくつかの利点があるため増加しています。そのため、複数の企業が、細菌やウイルスの病原体を早期に診断し、より良い患者管理のために、ポイントオブケア型の分子診断に投資しています。このように、敗血症診断における分子診断などの技術の利用は、中東・アフリカの敗血症診断市場で活動する新興の主要企業が追う重要な動向です。

中東・アフリカ敗血症診断市場の概要

中東・アフリカの主要国は、UAE、サウジアラビア、南アフリカの3カ国です。中東・アフリカの敗血症診断市場の成長は、医療費の増加、敗血症疾患の発生率の上昇、意識の高まり、市場プレイヤーによる革新的な診断製品の開拓などの要因に起因しています。

中東・アフリカの敗血症診断市場の収益と2028年までの予測

中東・アフリカの敗血症診断市場の細分化

中東・アフリカの敗血症診断市場は、製品、方法、検査タイプ、病原体、エンドユーザー、国に区分されます。

製品に基づき、中東・アフリカの敗血症診断市場は、機器、試薬・アッセイ、血液培養液、ソフトウェアに区分されます。2021年には、血液培養液セグメントが最大の市場シェアを占めています。

技術に基づき、中東・アフリカの敗血症診断市場は、分子診断、フローサイトメトリー、マイクロフルイディクス、イムノアッセイ、バイオマーカー、微生物学にセグメント化されます。2021年には微生物学分野が最大の市場シェアを占めています。分子診断分野の市場は、ポリメラーゼ連鎖反応、ペプチド核酸-蛍光in situハイブリダイゼーション、シンドロームパネルベース検査、マイクロアレイに細分化されます。

手法に基づき、中東・アフリカの敗血症診断市場は、自動診断と従来型診断に二分されます。2021年には、従来型診断法がより大きな市場シェアを占めています。

検査タイプに基づき、中東・アフリカの敗血症診断市場は、ポイントオブケア検査とラボラトリー検査に二分されます。2021年はラボラトリーテスト部門がより大きな市場シェアを占めました。

病原体に基づき、中東・アフリカの敗血症診断市場は細菌性敗血症、真菌性敗血症、その他に区分されます。2021年には細菌性敗血症セグメントが最も大きな市場シェアを占めています。

エンドユーザーに基づき、中東・アフリカの敗血症診断市場は、病院、病理学・参照研究所、その他に区分されます。2021年には病院セグメントが最大の市場シェアを占めました。

国別に見ると、中東・アフリカの敗血症診断市場は、サウジアラビア、南アフリカ、UAE、その他中東・アフリカに区分されます。2021年の市場シェアはサウジアラビアが独占しています。

Abbott社、BD社、bioMerieux SA社、Danaher社（Beckman Coulter）、F. HOFFMANN-LA ROCHE LTD社、T2 Biosystems社、THERMO FISHER SCIENTIFIC INC.などが中東・アフリカの敗血症診断市場で活動している主要企業です。

目次

第1章 イントロダクション

第2章 重要なポイント

第3章 調査手法

• カバレッジ
• 2次調査
• 1次調査

第4章 中東・アフリカの敗血症診断市場- 市場情勢

• 中東・アフリカのPEST分析
• 専門家の見解

第5章 中東・アフリカの敗血症診断市場- 主要な市場力学

• 市場促進要因
  • 院内感染の増加別敗血症の発症率の上昇
  • 迅速な診断テストに対する需要の高まりと、製品発売の増加
• 市場抑制要因
  • 熟練した専門家の不足
• 市場機会
  • 敗血症診断研究のための資金調達と支援の増加
• 今後の動向
  • 敗血症診断における技術的進歩の高まり
• 影響度分析

第6章 中東・アフリカの敗血症診断市場分析

• 中東・アフリカの敗血症診断市場収益と予測・分析

第7章 中東・アフリカの敗血症診断市場の収益と2028年までの予測- 製品別

• 中東・アフリカの敗血症診断市場、製品別、2021年・2028年（%）
• インストゥルメント
• 試薬およびアッセイ
• 血液培養培地
• ソフトウェア

第8章 中東・アフリカの敗血症診断市場の収益と2028年までの予測- 技術編

• 中東・アフリカの敗血症診断市場の技術別シェア-2021年・2028年（%）
• 分子診断薬
  • ポリメラーゼ連鎖反応
  • ペプチド核酸-蛍光インサイチュハイブリダイゼーション
  • シンドロミックパネルベースの検査
  • マイクロアレイ
• フローサイトメトリー
  • リアルタイムの細胞解析
    • TaqMan-Based Multiplex RT PCRと血液培養
    • レジーナ・マルゲリータ小児病院（イタリア、トリノ）で実施されたMagicplex（TM）Sepsis Real-Time Tests-ケーススタディ
    • 敗血症診断ソリューションの提供を手がける企業
    • リアルタイムPCR別敗血症診断
    • 次世代シーケンサーの新手法と技術の進歩・革新
    • インピーダンス測定別リアルタイム細胞解析
• マイクロフルイディクス
• イムノアッセイ
• バイオマーカー
  • メタボロミクス
    • 敗血症におけるメタボロームプロファイル
    • 敗血症診断におけるメタボロミクスの普及・利用形態
    • メタボロームプロファイリング別敗血症の早期予知
    • 敗血症の診断と治療におけるオミクスの今後の役割
    • 敗血症のバイオマーカーと診断ツール
    • 敗血症におけるメタボロミクスとプロテオミクスの役割
    • 急性腎不全の予後を予測する低分子バイオマーカー同定のためのアプローチとして期待されるもの
    • 敗血症診断におけるメタボロミクスの最新応用例
    • ミトコンドリア機能におけるメタボロミクス
    • ミトコンドリア医学の診断におけるメタボロミクスの大きな可能性
• 微生物学

第9章 中東・アフリカの敗血症診断市場の収益と2028年までの予測- 方法別

• 中東・アフリカの敗血症診断市場：方法別シェア-2021年・2028年（%）
• 自動化された診断法
• 従来型診断法

第10章 中東・アフリカの敗血症診断市場の収益と2028年までの予測- 検査タイプ別

• 中東・アフリカの敗血症診断市場の検査タイプ別シェア（2021年・2028年）（%）
• ポイントオブケア検査
• ラボラトリー検査

第11章 中東・アフリカの敗血症診断市場の収益と2028年までの予測- 病原体別

• 中東・アフリカの敗血症診断市場：病原体別シェア-2021年・2028年（%）
• 細菌性敗血症
• 真菌性敗血症
• その他

第12章 中東・アフリカの敗血症診断市場の収益と2028年までの予測- エンドユーザー別

• 中東・アフリカの敗血症診断市場のエンドユーザー別シェア-2021年・2028年（%）
• 病院
  • 病院
• 病理・レファレンスラボラトリー
• その他

第13章 中東・アフリカの敗血症診断市場の収益と2028年までの予測- 国別分析

• UAE（アラブ首長国連邦）
• サウジアラビア
• 南アフリカ
• その他中東とアフリカ

第14章 敗血症診断市場- 業界情勢

• 敗血症診断市場における成長戦略（%）
• 有機的展開
• 無機的開発

第15章 企業プロファイル

• Abbott
• F. HOFFMANN-LA ROCHE LTD.
• BD
• Danaher（Beckman Coulter）
• THERMO FISHER SCIENTIFIC INC.
• bioMerieux SA
• T2 Biosystems, Inc.

第16章 付録

List Of Tables

• Table 1. New next-generation sequencing techniques by Company
• Table 2. UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
• Table 3. UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
• Table 4. UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
• Table 5. UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
• Table 6. UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
• Table 7. UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
• Table 8. UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
• Table 9. Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
• Table 10. Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
• Table 11. Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
• Table 12. Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
• Table 13. Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
• Table 14. Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
• Table 15. Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
• Table 16. South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
• Table 17. South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
• Table 18. South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
• Table 19. South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
• Table 20. South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
• Table 21. South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
• Table 22. South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
• Table 23. Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
• Table 24. Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
• Table 25. Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
• Table 26. Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
• Table 27. Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
• Table 28. Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
• Table 29. Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
• Table 30. Recent Organic Growth Strategies in Sepsis Diagnostics Market
• Table 31. Inorganic Developments in the Sepsis Diagnostics Market
• Table 32. Glossary of Terms

List Of Figures

• Figure 1. Middle East & Africa Sepsis Diagnostics Market Segmentation
• Figure 2. Middle East & Africa Sepsis Diagnostics Market, By Country
• Figure 3. Middle East & Africa Sepsis Diagnostics Market Overview
• Figure 4. Blood Culture Media Segment Held Largest Share of Type Segment in Middle East & Africa Sepsis Diagnostics Market
• Figure 5. The UAE is Expected to Show Remarkable Growth During the Forecast Period
• Figure 6. Middle East & Africa: PEST Analysis
• Figure 7. Experts Opinion
• Figure 8. Middle East & Africa Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints
• Figure 9. Middle East & Africa Sepsis Diagnostics Market- Revenue Forecast and Analysis - 2020- 2028
• Figure 10. Middle East & Africa Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)
• Figure 11. Instruments: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 12. Reagents and Assays: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 13. Blood Culture Media: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 14. Software: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 15. Middle East & Africa Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
• Figure 16. Molecular Diagnostics: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 17. Polymerase Chain Reaction: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 18. Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 19. Syndromic Panel-Based Testing: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 20. Microarrays: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 21. Flow Cytometry: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 22. Real-Time Cell Analysis: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 23. Microfluidics: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 24. Immunoassay: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 25. Biomarkers: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 26. Metabolomics: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 27. Microbiology: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 28. Middle East & Africa Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
• Figure 29. Automated Diagnostics: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 30. Conventional Diagnostics: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 31. Middle East & Africa Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
• Figure 32. Point-of-Care Tests: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 33. Laboratory Tests: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 34. Middle East & Africa Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
• Figure 35. Bacterial Sepsis: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 36. Fungal Sepsis: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 37. Others: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 38. Middle East & Africa Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
• Figure 39. Hospitals: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 40. Pathology and Reference Laboratories: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 41. Others: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
• Figure 42. Middle East & Africa Sepsis Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)
• Figure 43. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
• Figure 44. UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 45. Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 46. South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 47. Rest of Middle East and Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 48. Growth Strategies in the Sepsis Diagnostics Market (%)

The Middle East & Africa sepsis diagnostics market is expected to grow from US$ 19.20 million in 2021 to US$ 33.35 million by 2028. It is estimated to record a CAGR of 8.2% from 2021 to 2028.

Rising Technological Advancements in Sepsis Diagnosis to Drive Middle East & Africa Sepsis Diagnostics Market Growth During 2021-2028

Technology is a critical parameter in healthcare diagnostics to provide accuracy and save time and resources. In the process of sepsis diagnosis, identification of the causative pathogen is essential in selecting appropriate antibiotic therapy as part of the treatment. Molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology are majorly used sepsis diagnostics techniques. Among all, molecular diagnostics (MDx) is an attractive approach to consider for sepsis diagnostics. The adoption of molecular diagnostic technology is increasing due to its several advantages, such as high sensitivity, accuracy, and less turnaround time than other technologies. Therefore, several companies are investing in point-of-care molecular diagnostics to diagnose bacterial and viral pathogens early and for better patient management. Thus, the rising use of technology such as molecular diagnostics in sepsis diagnosis is a crucial trend followed by emerging key players operating in the Middle East & Africa sepsis diagnostics market .

Middle East & Africa Sepsis Diagnostics Market Overview

The UAE, Saudi Arabia, and South Africa are three major countries in the Middle East & South Africa. The Middle East & Africa sepsis diagnostics market growth is attributed to factors such as growing healthcare expenditure, rising incidence of sepsis diseases, increasing awareness, and the development of innovative diagnostic products by the market players.

Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Sepsis Diagnostics Market Segmentation

The Middle East & Africa sepsis diagnostics market is segmented into product, method, test type, pathogen, end user, and country.

Based on product, the Middle East & Africa sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment held the largest market share in 2021.

Based on technology, the Middle East & Africa sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment held the largest market share in 2021. The market for the molecular diagnostics segment is sub segmented into polymerase chain reaction, peptide nucleic acid-fluorescent in situ hybridization, syndromic panel-based testing, and microarrays.

Based on method, the Middle East & Africa sepsis diagnostics market is bifurcated into automated diagnostics and conventional diagnostics. The conventional diagnostics segment held a larger market share in 2021.

Based on test type, the Middle East & Africa sepsis diagnostics market is bifurcated into point-of-care tests and laboratory tests. The laboratory tests segment held a larger market share in 2021.

Based on pathogen, the Middle East & Africa sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment held the largest market share in 2021.

Based on end user, the Middle East & Africa sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others. The hospitals segment held the largest market share in 2021.

Based on country, the Middle East & Africa sepsis diagnostics market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the market share in 2021.

Abbott; BD; bioMerieux SA; Danaher (Beckman Coulter); F. HOFFMANN-LA ROCHE LTD.; T2 Biosystems, Inc.; and THERMO FISHER SCIENTIFIC INC. are among the leading companies operating in the Middle East & Africa sepsis diagnostics market.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa sepsis diagnostics market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

• 1.1 Scope of the Study
• 1.2 The Insight Partners Research Report Guidance
• 1.3 Market Segmentation
  • 1.3.1 Middle East & Africa Sepsis Diagnostics Market - By Product
  • 1.3.2 Middle East & Africa Sepsis Diagnostics Market - By Technology
  • 1.3.3 Middle East & Africa Sepsis Diagnostics Market - By Method
  • 1.3.4 Middle East & Africa Sepsis Diagnostics Market - By Test Type
  • 1.3.5 Middle East & Africa Sepsis Diagnostics Market - By Pathogen
  • 1.3.6 Middle East & Africa Sepsis Diagnostics Market - By End User
  • 1.3.7 Middle East & Africa Sepsis Diagnostics Market - By Country

2. Key Takeaways

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Middle East & Africa Sepsis Diagnostics Market -Market Landscape

• 4.1 Overview
• 4.2 Middle East & Africa PEST Analysis
• 4.3 Experts Opinion

5. Middle East & Africa Sepsis Diagnostics Market - Key Market Dynamics

• 5.1 Market Drivers
  • 5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections
  • 5.1.2 Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
• 5.2 Market Restraints
  • 5.2.1 Lack of Skilled Professionals
• 5.3 Market Opportunities
  • 5.3.1 Increase in Funding and Support for Sepsis Diagnostics Research
• 5.4 Future Trends
  • 5.4.1 Rising Technological Advancements in Sepsis Diagnosis
• 5.5 Impact Analysis

6. Sepsis Diagnostics Market- Middle East & Africa Analysis

• 6.1 Middle East & Africa Sepsis Diagnostics Market Revenue Forecast and Analysis

7. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028- by Product

• 7.1 Overview
• 7.2 Middle East & Africa Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
• 7.3 Instruments
  • 7.3.1 Overview
  • 7.3.2 Instruments: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
• 7.4 Reagents and Assays
  • 7.4.1 Overview
  • 7.4.2 Reagents and Assays: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
• 7.5 Blood Culture Media
  • 7.5.1 Overview
  • 7.5.2 Blood Culture Media: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
• 7.6 Software
  • 7.6.1 Overview
  • 7.6.2 Software: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Technology

• 8.1 Overview
• 8.2 Middle East & Africa Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
• 8.3 Molecular Diagnostics
  • 8.3.1 Overview
  • 8.3.2 Molecular Diagnostics: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    • 8.3.2.1 Polymerase Chain Reaction
      • 8.3.2.1.1 Overview
      • 8.3.2.1.2 Polymerase Chain Reaction: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    • 8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
      • 8.3.2.2.1 Overview
      • 8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    • 8.3.2.3 Syndromic Panel-Based Testing
      • 8.3.2.3.1 Overview
      • 8.3.2.3.2 Syndromic Panel-Based Testing: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    • 8.3.2.4 Microarrays
      • 8.3.2.4.1 Overview
      • 8.3.2.4.2 Microarrays: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
• 8.4 Flow Cytometry
  • 8.4.1 Overview
  • 8.4.2 Flow Cytometry: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4.3 Real-Time Cell Analysis
    • 8.4.3.1 TaqMan-Based Multiplex RT PCR and Blood Culture
      • 8.4.3.1.1 Characteristics of TaqMan Assays
    • 8.4.3.2 Magicplex (TM)Sepsis Real-Time Tests Performed in Tertiary Regina Margherita Children's Hospital (Turin, Italy) - Case Study
      • 8.4.3.2.1 Abstract
      • 8.4.3.2.2 Conclusion:
    • 8.4.3.3 Companies that are engaged in providing Sepsis Diagnostic solutions
    • 8.4.3.4 Sepsis diagnosis by real-time PCR
    • 8.4.3.5 New next-generation sequencing technique and technological advancements/innovations
    • 8.4.3.6 Real Time Cellular Analysis Using Impedance Measurements
  • 8.4.4 Real-Time Cell Analysis: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
• 8.5 Microfluidics
  • 8.5.1 Overview
  • 8.5.2 Microfluidics: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
• 8.6 Immunoassay
  • 8.6.1 Overview
  • 8.6.2 Immunoassay: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
• 8.7 Biomarkers
  • 8.7.1 Overview
  • 8.7.2 Biomarkers: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.7.3 Metabolomics
    • 8.7.3.1 Metabolite Profile in Sepsis
    • 8.7.3.2 Penetration/Usage Pattern of Metabolomics in Sepsis Diagnosis
    • 8.7.3.3 Early Prediction of Sepsis by Metabolite Profiling
    • 8.7.3.4 Future Role of Omics in Diagnosis and Therapy of Sepsis
      • 8.7.3.4.1 Genomics
      • 8.7.3.4.2 Proteomics
    • 8.7.3.5 Sepsis Biomarkers and Diagnostic Tools
    • 8.7.3.6 Role Metabolomics and Proteomics in Sepsis
    • 8.7.3.7 Potential Approach for Identifying Small Molecule Biomarkers for Acute Kidney Disease Prognosis
    • 8.7.3.8 Recent Application of Metabolomics in Sepsis Diagnosis
    • 8.7.3.9 Metabolics in Mitochondrial Function
    • 8.7.3.10 Substantial Potential of Metabolomics in Diagnostics for Mitochondrial Medicine
  • 8.7.4 Metabolomics: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
• 8.8 Microbiology
  • 8.8.1 Overview
  • 8.8.2 Microbiology: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Method

• 9.1 Overview
• 9.2 Middle East & Africa Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
• 9.3 Automated Diagnostics
  • 9.3.1 Overview
  • 9.3.2 Automated Diagnostics: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
• 9.4 Conventional Diagnostics
  • 9.4.1 Overview
  • 9.4.2 Conventional Diagnostics: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Test Type

• 10.1 Overview
• 10.2 Middle East & Africa Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
• 10.3 Point-of-Care Tests
  • 10.3.1 Overview
  • 10.3.2 Point-of-Care Tests: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
• 10.4 Laboratory Tests
  • 10.4.1 Overview
  • 10.4.2 Laboratory Tests: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Pathogen

• 11.1 Overview
• 11.2 Middle East & Africa Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
• 11.3 Bacterial Sepsis
  • 11.3.1 Overview
  • 11.3.2 Bacterial Sepsis: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
• 11.4 Fungal Sepsis
  • 11.4.1 Overview
  • 11.4.2 Fungal Sepsis: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
• 11.5 Others
  • 11.5.1 Overview
  • 11.5.2 Others: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 - End User

• 12.1 Overview
• 12.2 Middle East & Africa Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
• 12.3 Hospitals
  • 12.3.1 Overview
  • 12.3.2 Hospitals: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
• 12.4 Pathology and Reference Laboratories
  • 12.4.1 Overview
  • 12.4.2 Pathology and Reference Laboratories: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
• 12.5 Others
  • 12.5.1 Overview
  • 12.5.2 Others: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

13. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 - Country Analysis

• 13.1 Overview
  • 13.1.1 Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
    • 13.1.1.1 UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
      • 13.1.1.1.1 Overview
      • 13.1.1.1.2 UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
      • 13.1.1.1.3 UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
      • 13.1.1.1.4 UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
      • 13.1.1.1.4.1 Biomarkers: Metabolomics 2019-2028
      • 13.1.1.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
      • 13.1.1.1.4.3 UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
      • 13.1.1.1.5 UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
      • 13.1.1.1.6 UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
      • 13.1.1.1.7 UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
      • 13.1.1.1.8 UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
    • 13.1.1.2 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
      • 13.1.1.2.1 Overview
      • 13.1.1.2.2 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
      • 13.1.1.2.3 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
      • 13.1.1.2.4 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
      • 13.1.1.2.4.1 Biomarkers: Metabolomics 2019-2028
      • 13.1.1.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
      • 13.1.1.2.4.3 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
      • 13.1.1.2.5 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
      • 13.1.1.2.6 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
      • 13.1.1.2.7 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
      • 13.1.1.2.8 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
    • 13.1.1.3 South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
      • 13.1.1.3.1 Overview
      • 13.1.1.3.2 South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
      • 13.1.1.3.3 South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
      • 13.1.1.3.4 South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
      • 13.1.1.3.4.1 Biomarkers: Metabolomics 2019-2028
      • 13.1.1.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
      • 13.1.1.3.4.3 South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
      • 13.1.1.3.5 South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
      • 13.1.1.3.6 South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
      • 13.1.1.3.7 South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
      • 13.1.1.3.8 South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
    • 13.1.1.4 Rest of Middle East and Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
      • 13.1.1.4.1 Overview
      • 13.1.1.4.2 Rest of Middle East and Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
      • 13.1.1.4.3 Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
      • 13.1.1.4.4 Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
      • 13.1.1.4.4.1 Biomarkers: Metabolomics 2019-2028
      • 13.1.1.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
      • 13.1.1.4.4.3 Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
      • 13.1.1.4.5 Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
      • 13.1.1.4.6 Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
      • 13.1.1.4.7 Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
      • 13.1.1.4.8 Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

14. Sepsis Diagnostics Market-Industry Landscape

• 14.1 Overview
• 14.2 Growth Strategies in the Sepsis Diagnostics Market (%)
• 14.3 Organic Developments
  • 14.3.1 Overview
• 14.4 Inorganic Developments
  • 14.4.1 Overview

15. Company Profiles

• 15.1 Abbott
  • 15.1.1 Key Facts
  • 15.1.2 Business Description
  • 15.1.3 Products and Services
  • 15.1.4 Financial Overview
  • 15.1.5 SWOT Analysis
  • 15.1.6 Key Developments
• 15.2 F. HOFFMANN-LA ROCHE LTD.
  • 15.2.1 Key Facts
  • 15.2.2 Business Description
  • 15.2.3 Products and Services
  • 15.2.4 Financial Overview
  • 15.2.5 SWOT Analysis
  • 15.2.6 Key Developments
• 15.3 BD
  • 15.3.1 Key Facts
  • 15.3.2 Business Description
  • 15.3.3 Products and Services
  • 15.3.4 Financial Overview
  • 15.3.5 SWOT Analysis
  • 15.3.6 Key Developments
• 15.4 Danaher (Beckman Coulter)
  • 15.4.1 Key Facts
  • 15.4.2 Business Description
  • 15.4.3 Products and Services
  • 15.4.4 Financial Overview
  • 15.4.5 SWOT Analysis
  • 15.4.6 Key Developments
• 15.5 THERMO FISHER SCIENTIFIC INC.
  • 15.5.1 Key Facts
  • 15.5.2 Business Description
  • 15.5.3 Products and Services
  • 15.5.4 Financial Overview
  • 15.5.5 SWOT Analysis
  • 15.5.6 Key Developments
• 15.6 bioMerieux SA
  • 15.6.1 Key Facts
  • 15.6.2 Business Description
  • 15.6.3 Products and Services
  • 15.6.4 Financial Overview
  • 15.6.5 SWOT Analysis
  • 15.6.6 Key Developments
• 15.7 T2 Biosystems, Inc.
  • 15.7.1 Key Facts
  • 15.7.2 Business Description
  • 15.7.3 Products and Services
  • 15.7.4 Financial Overview
  • 15.7.5 SWOT Analysis
  • 15.7.6 Key Developments

16. Appendix

• 16.1 About the Insight Partners
• 16.2 Glossary of Terms